Factores asociados a sobrevida a un año en pacientes postoperados de glioblastoma.

IF 0.5 4区 医学 Q4 SURGERY
Gerardo Del C Palacios-Saucedo, Juan J Padilla-Martínez, Alejandra G Dávila-Gaytán, Celia G Herrera-Rivera, José M Vázquez-Guillén, Lydia G Rivera-Morales, José R Cortés-Cárdenas, Cristina Rodríguez-Padilla
{"title":"Factores asociados a sobrevida a un año en pacientes postoperados de glioblastoma.","authors":"Gerardo Del C Palacios-Saucedo,&nbsp;Juan J Padilla-Martínez,&nbsp;Alejandra G Dávila-Gaytán,&nbsp;Celia G Herrera-Rivera,&nbsp;José M Vázquez-Guillén,&nbsp;Lydia G Rivera-Morales,&nbsp;José R Cortés-Cárdenas,&nbsp;Cristina Rodríguez-Padilla","doi":"10.24875/CIRU.21000130","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To identify factors associated with one-year survival in postoperative glioblastoma patients at a hospital in northeastern Mexico.</p><p><strong>Material and methods: </strong>Nested case-control study. Patients operated on for glioblastoma between 2016-2019 were included. Information about clinical and surgical factors was obtained, survival was calculated by Kaplan-Meier analysis. Descriptive analysis was performed with medians and ranges, and inferential analysis with χ<sup>2</sup>, Fisher and Student t test, odds ratio and 95% confidence interval. A value of p < 0.05 was considered significant.</p><p><strong>Results: </strong>Sixty-two patients with glioblastoma were included, 27 (43.5%) women and 35 (56.5%) men, median age 56 years (range: 6-83). Median survival was 3.6 months (1-52), 45 (72.6%) survived less than 12 months. The factors associated with a higher survival were administration of adjuvant treatment (p < 0.001), better functional status (p = 0.001), and absence of post-surgical complications (p = 0.034).</p><p><strong>Conclusions: </strong>Most patients with glioblastoma survive less than 12 months and the factors most strongly associated with longer survival are administration of adjuvant treatment, better functional status of the patient and absence of post-surgical complications.</p>","PeriodicalId":50990,"journal":{"name":"Cirugia Y Cirujanos","volume":"91 3","pages":"397-402"},"PeriodicalIF":0.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cirugia Y Cirujanos","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.24875/CIRU.21000130","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To identify factors associated with one-year survival in postoperative glioblastoma patients at a hospital in northeastern Mexico.

Material and methods: Nested case-control study. Patients operated on for glioblastoma between 2016-2019 were included. Information about clinical and surgical factors was obtained, survival was calculated by Kaplan-Meier analysis. Descriptive analysis was performed with medians and ranges, and inferential analysis with χ2, Fisher and Student t test, odds ratio and 95% confidence interval. A value of p < 0.05 was considered significant.

Results: Sixty-two patients with glioblastoma were included, 27 (43.5%) women and 35 (56.5%) men, median age 56 years (range: 6-83). Median survival was 3.6 months (1-52), 45 (72.6%) survived less than 12 months. The factors associated with a higher survival were administration of adjuvant treatment (p < 0.001), better functional status (p = 0.001), and absence of post-surgical complications (p = 0.034).

Conclusions: Most patients with glioblastoma survive less than 12 months and the factors most strongly associated with longer survival are administration of adjuvant treatment, better functional status of the patient and absence of post-surgical complications.

胶质母细胞瘤术后1年生存率的相关因素。
目的:确定与墨西哥东北部一家医院胶质母细胞瘤术后患者一年生存率相关的因素。材料与方法:巢式病例对照研究。纳入了2016-2019年间因胶质母细胞瘤手术的患者。获得临床和手术因素信息,通过Kaplan-Meier分析计算生存率。采用中位数和极差进行描述性分析,采用χ2、Fisher和Student t检验、优势比和95%置信区间进行推理分析。p < 0.05为显著性。结果:纳入62例胶质母细胞瘤患者,女性27例(43.5%),男性35例(56.5%),中位年龄56岁(范围:6-83岁)。中位生存期为3.6个月(1-52),45例(72.6%)生存期不足12个月。与高生存率相关的因素是给予辅助治疗(p < 0.001),较好的功能状态(p = 0.001)和无术后并发症(p = 0.034)。结论:大多数胶质母细胞瘤患者的生存期小于12个月,与生存期延长最密切相关的因素是给予辅助治疗、患者良好的功能状态和无术后并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cirugia Y Cirujanos
Cirugia Y Cirujanos 医学-外科
CiteScore
0.90
自引率
20.00%
发文量
207
审稿时长
6-12 weeks
期刊介绍: Cirugía y Cirujanoses exponente del desarrollo académico, científico, médico, quirúrgico y tecnológico en materia de salud en México y en el ámbito internacional. Es una revista bimestral, open access, revisada por pares, que publica en español y en inglés (traducido sin coste para los autores) artículos científicos originales, casos clínicos, artículos de revisión de interés general y cartas al editor. Los artículos se seleccionan y publican siguiendo un riguroso análisis, de acuerdo con los estándares internacionalmente aceptados. Sus espacios están abiertos a los académicos, así como a todo miembro de la comunidad médica que manifieste interés por utilizar este foro para publicar sus trabajos.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信